Antiretroviral roll-out, antifungal roll-back: access to treatment for cryptococcal meningitis.

[1]  N. White,et al.  Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial , 2004, The Lancet.

[2]  D. Denning,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Microbiology Standards of Care British Society for Medical Mycology Proposed Standards of Care for Patients with Invasive Fungal Infections , 2022 .

[3]  N. French,et al.  Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults , 2002, AIDS.

[4]  R. Hayes,et al.  Morbidity and mortality in South African gold miners: impact of untreated disease due to human immunodeficiency virus. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  K. Nelson,et al.  Clinical presentation and risk behaviors of patients with acquired immunodeficiency syndrome in Thailand, 1994--1998: regional variation and temporal trends. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  J. Perfect,et al.  Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  M. Saag,et al.  Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. , 1997, The New England journal of medicine.

[8]  L. Chan,et al.  Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial. , 1990, Annals of internal medicine.